Characteristics and clinical course of younger patients with asymptomatic monoclonal gammopathies

Eirini Solia1, Foteini Theodorakakou1, Panagiotis Malandrakis1

  • 1Department of Clinical Therapeutics, Alexandra General Hospital, National and Kapodistrian University of Athens, Athens, Greece.

Insights

Younger patients with monoclonal gammopathies like MGUS, SMM, and aWM show similar biological traits and low progression rates compared to older adults. Protocolized follow-up suggests early detection is safe and effective.

Area of Science:

  • Hematology
  • Oncology
  • Clinical Research

Background:

  • Monoclonal gammopathies of undetermined significance (MGUS), smouldering multiple myeloma (SMM), and asymptomatic Waldenström's macroglobulinaemia (aWM) are precursor plasma cell disorders.
  • These conditions carry a variable risk of progressing to symptomatic hematologic malignancies.
  • Characterizing these precursor conditions in younger populations is crucial for understanding disease trajectories.

Purpose of the Study:

  • To investigate the clinical characteristics and progression patterns of asymptomatic monoclonal gammopathies in patients under 50 and 40 years of age.
  • To compare the progression rates and risk factors in younger patients versus older cohorts.
  • To evaluate the safety and efficacy of protocolized follow-up in this demographic.

Main Methods:

  • Retrospective analysis of 1237 consecutive patients with monoclonal gammopathies.
  • Subgroup analysis of patients <50 years and <40 years, detailing MGUS, SMM, and aWM prevalence.
  • Assessment of progression using SLiM criteria and bone lesion detection; comparison of SMM progression rates adjusted for baseline risk (20/2/20 criteria).

Main Results:

  • Patients <50 years showed a predominance of MGUS and a female demographic; patients <40 years were 71% female, with equal SMM and MGUS prevalence.
  • Progression in patients <50 years occurred via SLiM criteria or bone lesions, with lower 2, 3, and 5-year SMM progression rates (4%, 6%, 12%) compared to older patients (9%, 13%, 20%) before risk adjustment.
  • No patient <50 years with MGUS or aWM progressed; no SMM patients <40 years at high risk progressed within a 3-year median follow-up.

Conclusions:

  • Younger patients (<50 and <40 years) with asymptomatic monoclonal gammopathies share biological features with older patients.
  • Progression rates in younger SMM patients are generally low and comparable to older patients when adjusted for risk.
  • Protocolized surveillance appears safe for younger individuals with MGUS, aWM, and low-risk SMM, indicating a low risk of complications.

Related Concept Videos

Myocarditis II: Clinical Features and Diagnostic Tests01:27

Myocarditis II: Clinical Features and Diagnostic Tests

Myocarditis is an inflammation of the heart muscle. The symptoms vary widely, encompassing asymptomatic presentations to severe, acute manifestations.Clinical PresentationAsymptomatic cases: In some instances, myocarditis may be asymptomatic, with the infection resolving without intervention. These cases often go undetected unless discovered incidentally through diagnostic imaging or tests conducted for other reasons.General Early Symptoms: Early symptoms of myocarditis are non-specific and can...
Atypical Pneumonia01:14

Atypical Pneumonia

Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease include...
Graves Disease II: Pathophysiology01:24

Graves Disease II: Pathophysiology

Graves’ disease is an autoimmune disorder characterized by the production of thyroid-stimulating immunoglobulins (TSI) that activate TSH receptors, leading to excessive synthesis and release of thyroid hormones (T3 and T4) and resulting in hyperthyroidism.Among all causes of hyperthyroidism, Graves’ disease is the most common and can happen at any age, though it is more frequent in women. It produces a hypermetabolic state with features such as weight loss, tachycardia, tremor, and heat...
Graves' Disease I: Introduction01:28

Graves' Disease I: Introduction

Graves' disease is an autoimmune disorder that causes hyperthyroidism, or overactivity of the thyroid gland. It results from autoantibodies called thyroid-stimulating immunoglobulins (TSIs), which bind to thyroid-stimulating hormone (TSH) receptors, leading to overstimulation of hormone production and a hypermetabolic state.EtiologyAlthough considered idiopathic, Graves’ disease has well-established contributing factors. There is a strong genetic component, with increased prevalence in...
Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
Cytomegalovirus Disease01:27

Cytomegalovirus Disease

Cytomegalovirus (CMV) disease is caused by human cytomegalovirus, a double-stranded DNA virus of the Herpesviridae family. While primary CMV infection is often asymptomatic in immunocompetent individuals, the virus can cause severe disease in neonates and immunocompromised patients. CMV is the most common cause of congenital viral infection in the United States, and a major pathogen in solid organ and hematopoietic stem cell transplant recipients.CMV is transmitted via bodily fluids, sexual...